Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
Katikati, Bay of Plenty-based Eqalis operates in Pharmaceutical Manufacturing. Privately held, at eqalis.co.nz. It holds one address on record, all in New Zealand. It employs 5 people, on the record. Its latest round on record is Grant, US$2.9K. It is listed alongside ten similar brands, mostly in Pharmaceutical Manufacturing.
Eqalis is pioneering medicinal cannabis in New Zealand.
| Countries | 1 |
|---|---|
| Primary country | NZ |
All codes: NZ
| Rounds | 1 |
|---|---|
| Axis | 2019 to 2026 |
| Grant · 1 Jun 2020 | US$ 2.9K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
5 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, New Zealand only. Primary: Katikati, Bay of Plenty 3129.
One round. Latest 1 June 2020: grant, US$2,900, investor Callaghan Innovation.
10 profiles list Eqalis as a peer — 85th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Kāriki Pharma and NUBU list it back.